Literature DB >> 52183

A surface antigen marker for human monocytes.

M F Greaves, J A Falk, R E Falk.   

Abstract

Antisera have been raised in rabbits aginst human peritoneal macrophages. After absorption with tonsil cells the sera reacted, by direct and indirect immunfluorescence, with phagocytic mononuclear cells from a variety of tissues and, in addition, stained a small population of nonphagocytic non-T, non-B mononuclear cells present in blood, spleen, and marrow but absent or very rare in tonsil and thymus. The antisera may define a human monocyte-macrophage cell surface differentiation antigen (HuMA) and can be used to deplete or enrich reactive cell population.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 52183     DOI: 10.1111/j.1365-3083.1975.tb02661.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  5 in total

1.  Partial molecular characterization of an antigenic structure associated to cells of common acute lymphocytic leukaemia (ALL).

Authors:  H Kabisch; R Arndt; H G Thiele; K Winkler; G Landbeck
Journal:  Clin Exp Immunol       Date:  1978-06       Impact factor: 4.330

2.  Human B-lymphocyte heteroantigens: direct evidence for specificities not shared by monocytes.

Authors:  D Espinouse; F Touraine; D Schmitt; J L Touraine
Journal:  Clin Exp Immunol       Date:  1978-12       Impact factor: 4.330

3.  Immunologic diagnosis and monitoring of human acute leukemias: a review.

Authors:  M Maheu; M A Baker; J A Falk; R N Taub
Journal:  Am J Pathol       Date:  1981-04       Impact factor: 4.307

4.  Rosette formation with mouse erythrocytes. IV. T, B and third population cells in human tonsils.

Authors:  S Gupta; R Pahwa; F P Siegal; R A Good
Journal:  Clin Exp Immunol       Date:  1977-05       Impact factor: 4.330

5.  Large mononuclear (veiled) cells like 'Ia-like' membrane antigens in human afferent lympn.

Authors:  C J Spry; A J Pflug; G Janossy; J H Humphrey
Journal:  Clin Exp Immunol       Date:  1980-03       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.